Search research articles
Contact Us
Filters
Showing results (111-120 of 128) with videos related to
Page
of 13
Sort By:
Archives Des Maladies Du Coeur Et Des Vaisseaux
|
August 1, 1997
[Autonomic nervous system abnormalities in the initial phase of insulin resistance syndrome. Value of the study of variability of cardiac rate and blood pressure on a model of nutritional obesity]
P Verwaerde, M Galinier, J Fourcade, et al.
Archives Des Maladies Du Coeur Et Des Vaisseaux
|
August 1, 1993
[Beta-adrenergic receptivity and left ventricular hypertrophy caused by pressure overload in man]
M Galinier, J M Senard, P Valet, et al.
Journal of Cardiac Failure
|
September 19, 2001
Rehabilitation of patients with congestive heart failure with or without beta-blockade therapy
D Curnier, M Galinier, A Pathak, et al.
Journal of Interventional Cardiac Electrophysiology : an International Journal of Arrhythmias and Pacing
|
May 9, 2001
Prognostic value of heart rate variability in time domain analysis in congestive heart failure
S Boveda, M Galinier, A Pathak, et al.
Archives Des Maladies Du Coeur Et Des Vaisseaux
|
August 1, 1994
[Changes in myocardial beta adrenergic receptors in left ventricular hypertrophy caused by barometric and volumetric overloads]
M Galinier, J M Senard, A Srour, et al.
European Journal of Clinical Pharmacology
|
January 1, 1993
The effect of yohimbine on sympathetic responsiveness in essential hypertension
C Damase-Michel, M A Tran, M E Llau, et al.
The Journal of Clinical Investigation
|
May 1, 1993
Characterization and distribution of alpha 2-adrenergic receptors in the human intestinal mucosa
P Valet, J M Senard, J C Devedjian, et al.
Journal of Neurology, Neurosurgery, and Psychiatry
|
May 1, 1994
Normal activation of the supplementary motor area in patients with Parkinson's disease undergoing long-term treatment with levodopa
O Rascol, U Sabatini, F Chollet, et al.
Brain : a Journal of Neurology
|
April 29, 1998
Cortical motor overactivation in parkinsonian patients with L-dopa-induced peak-dose dyskinesia
O Rascol, U Sabatini, C Brefel, et al.
Movement Disorders : Official Journal of the Movement Disorder Society
|
August 1, 1998
Efaroxan, an alpha-2 antagonist, in the treatment of progressive supranuclear palsy
O Rascol, K Sieradzan, H Peyro-Saint-Paul, et al.
Page
of 13
Search research articles
Search
Showing results (111-120 of 128) with videos related to
Sort By:
Page
of 13
Archives Des Maladies Du Coeur Et Des Vaisseaux
|
August 1, 1997
[Autonomic nervous system abnormalities in the initial phase of insulin resistance syndrome. Value of the study of variability of cardiac rate and blood pressure on a model of nutritional obesity]
P Verwaerde, M Galinier, J Fourcade, et al.
Archives Des Maladies Du Coeur Et Des Vaisseaux
|
August 1, 1993
[Beta-adrenergic receptivity and left ventricular hypertrophy caused by pressure overload in man]
M Galinier, J M Senard, P Valet, et al.
Journal of Cardiac Failure
|
September 19, 2001
Rehabilitation of patients with congestive heart failure with or without beta-blockade therapy
D Curnier, M Galinier, A Pathak, et al.
Journal of Interventional Cardiac Electrophysiology : an International Journal of Arrhythmias and Pacing
|
May 9, 2001
Prognostic value of heart rate variability in time domain analysis in congestive heart failure
S Boveda, M Galinier, A Pathak, et al.
Archives Des Maladies Du Coeur Et Des Vaisseaux
|
August 1, 1994
[Changes in myocardial beta adrenergic receptors in left ventricular hypertrophy caused by barometric and volumetric overloads]
M Galinier, J M Senard, A Srour, et al.
European Journal of Clinical Pharmacology
|
January 1, 1993
The effect of yohimbine on sympathetic responsiveness in essential hypertension
C Damase-Michel, M A Tran, M E Llau, et al.
The Journal of Clinical Investigation
|
May 1, 1993
Characterization and distribution of alpha 2-adrenergic receptors in the human intestinal mucosa
P Valet, J M Senard, J C Devedjian, et al.
Journal of Neurology, Neurosurgery, and Psychiatry
|
May 1, 1994
Normal activation of the supplementary motor area in patients with Parkinson's disease undergoing long-term treatment with levodopa
O Rascol, U Sabatini, F Chollet, et al.
Brain : a Journal of Neurology
|
April 29, 1998
Cortical motor overactivation in parkinsonian patients with L-dopa-induced peak-dose dyskinesia
O Rascol, U Sabatini, C Brefel, et al.
Movement Disorders : Official Journal of the Movement Disorder Society
|
August 1, 1998
Efaroxan, an alpha-2 antagonist, in the treatment of progressive supranuclear palsy
O Rascol, K Sieradzan, H Peyro-Saint-Paul, et al.
Page
of 13